Profile data is unavailable for this security.
About the company
Jiangsu Jibeier Pharmaceutical Co Ltd is a company engaged in the research, development, production and sales of drugs. The Company's products are comprised of tablets, capsules and eye drops. The tablet products include Leucogen tablets, Nitrendipine and Atenolol tablets, Aceclofenac Enteric-coated tablets and Asarone tablets. The Company's products are used to improve white blood cells, treat high blood pressure, eye infections and other diseases.
- Revenue in CNY (TTM)889.82m
- Net income in CNY233.59m
- Incorporated2001
- Employees1.45k
- LocationJiangsu Jibeier Pharmaceutical Co LtdHigh-tech Industry Development ZoneZhenjiang 212000ChinaCHN
- Phone+86 51 188898101
- Fax+86 51 188889488
- Websitehttps://www.jbepharm.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Zhejiang Starry Pharmaceutical Co Ltd | 2.27bn | 46.95m | 3.93bn | 1.85k | 65.57 | 1.74 | -- | 1.73 | 0.1368 | 0.1368 | 6.63 | 5.15 | 0.4179 | 1.98 | 5.09 | 1,231,642.00 | 0.8789 | 3.30 | 1.80 | 5.97 | 23.86 | 32.35 | 2.10 | 8.21 | 0.4121 | 1.44 | 0.6405 | 53.08 | 3.04 | 19.78 | 158.32 | -13.94 | 10.39 | -- |
| Shanghai Hile Bio-Technology Co Ltd | 239.79m | 44.92m | 3.99bn | 295.00 | 90.58 | 3.19 | -- | 16.63 | 0.0669 | 0.0669 | 0.3664 | 1.90 | 0.154 | 1.06 | 2.40 | 812,857.50 | 2.06 | 1.73 | 2.56 | 2.47 | 45.19 | 50.44 | 13.37 | 10.37 | 1.16 | -- | 0.0562 | 23.89 | -19.76 | -1.11 | -48.30 | 24.17 | -41.32 | 23.47 |
| Yabao Pharmaceutical Group Co Ltd | 2.88bn | 204.43m | 4.02bn | 4.14k | 20.26 | 1.38 | -- | 1.39 | 0.2754 | 0.2754 | 3.81 | 4.05 | 0.7193 | 2.98 | 6.79 | 695,432.10 | 4.52 | 2.82 | 5.90 | 3.97 | 56.00 | 59.20 | 6.29 | 4.19 | 1.62 | 47.13 | 0.0675 | 43.74 | 7.05 | -0.0572 | 90.71 | -6.10 | 7.98 | -9.71 |
| Jiangsu Jibeier Pharmaceutical Co Ltd | 889.82m | 233.59m | 4.04bn | 1.45k | 16.54 | 1.99 | -- | 4.55 | 1.24 | 1.24 | 4.74 | 10.37 | 0.426 | 3.13 | 5.33 | 615,794.80 | 11.17 | 9.77 | 12.06 | 10.66 | 87.87 | 88.44 | 26.22 | 23.29 | 6.76 | -- | 0.005 | 30.68 | 31.49 | 12.16 | 41.65 | 17.79 | 112.78 | -- |
| Shanghai Haixin Group Co Ltd | 1.11bn | 171.70m | 4.17bn | 760.00 | 32.56 | 1.41 | -- | 3.76 | 0.1422 | 0.1422 | 0.9185 | 3.27 | 0.2246 | 7.19 | 9.32 | 1,458,849.00 | 4.05 | 2.68 | 4.57 | 3.06 | 46.37 | 44.55 | 18.02 | 11.17 | 2.83 | -- | 0.0089 | 36.10 | -17.88 | 1.48 | 1.20 | 4.19 | -10.27 | 13.18 |
| ZhuZhou QianJin Pharmaceutical Co., Ltd | 3.84bn | 322.70m | 4.21bn | 5.34k | 13.15 | 1.70 | -- | 1.10 | 0.7546 | 0.7546 | 8.94 | 5.82 | 0.8283 | 3.58 | 9.76 | 719,592.90 | 8.61 | 8.99 | 16.26 | 16.21 | 45.46 | 44.59 | 10.40 | 10.03 | 1.95 | -- | 0.1297 | 68.27 | -5.66 | 2.68 | 5.53 | 4.64 | -1.06 | -2.64 |
| Pulike Biological Engineering Inc | 1.18bn | 136.36m | 4.21bn | 1.68k | 30.82 | 1.54 | -- | 3.56 | 0.3946 | 0.3946 | 3.39 | 7.91 | 0.359 | 2.39 | 2.65 | 704,310.60 | 4.14 | 7.64 | 4.81 | 8.96 | 60.96 | 62.57 | 11.53 | 17.85 | 2.58 | 148.40 | 0.0146 | 52.48 | 1.84 | 15.55 | 3.99 | 5.17 | 41.58 | 18.47 |
Data as of Jul 26 2024. Currency figures normalised to Jiangsu Jibeier Pharmaceutical Co Ltd's reporting currency: Chinese Yuan Renminbi CNY
6.76%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Zhong Ou Asset Management Co., Ltdas of 31 Dec 2023 | 3.68m | 2.19% |
| Everbright PGIM Fund Management Co. Ltd.as of 31 Dec 2023 | 1.50m | 0.89% |
| Da Cheng Fund Management Co., Ltd.as of 31 Dec 2023 | 1.28m | 0.76% |
| Cinda Fund Management Co. Ltd.as of 31 Dec 2023 | 1.01m | 0.60% |
| China Universal Asset Management Co., Ltd.as of 31 Dec 2023 | 1.01m | 0.60% |
| GF Fund Management Co., Ltd.as of 31 Dec 2023 | 840.23k | 0.50% |
| China Fund Management Co., Ltd.as of 31 Dec 2023 | 716.14k | 0.43% |
| China Southern Asset Management Co., Ltd.as of 31 Dec 2023 | 562.78k | 0.33% |
| AXA-SPDB Investment Managers Co., Ltd.as of 31 Dec 2023 | 477.17k | 0.28% |
| Huatai Securities (Shanghai) Asset Management Co., Ltd.as of 31 Dec 2023 | 316.73k | 0.19% |
More ▼
Data from 31 Dec 2023 - 30 Jun 2024Source: FactSet Research Systems Inc.
